Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2-Reference-Cited by-同舟云学术

Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2

Published:2022-02-23 Issue:1 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Fujigaki Hidetsugu¹^ORCID,Yamamoto Yasuko¹,Koseki Takenao²³,Banno Sumi³,Ando Tatsuya⁴,Ito Hiroyasu⁴,Fujita Takashi⁵,Naruse Hiroyuki⁶,Hata Tadayoshi⁶,Moriyama Saya⁷,Takahashi Yoshimasa⁷,Suzuki Tadaki⁸,Murakami Takahiro⁹,Yoshida Yukihiro⁹,Yagura Yo⁹,Oyamada Takayoshi¹⁰,Takemura Masao¹,Kondo Masashi³¹¹,Iwata Mitsunaga¹²,Saito Kuniaki¹

Affiliation:

1. Department of Advanced Diagnostic System Development, Fujita Health University Graduate School of Health Sciences, Toyoake, Aichi, Japan

2. Department of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

3. Center for Clinical Trial and Research Support, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

4. Department of Joint Research Laboratory of Clinical Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

5. Department of Clinical Laboratory, Fujita Health University Hospital, Toyoake, Aichi, Japan

6. Department of Medical Laboratory Science, Fujita Health University Graduate School of Health Sciences, Toyoake, Aichi, Japan

7. Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan

8. Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan

9. Diagnostics Research Laboratories, Diagnostics Technical Service & Research Operations, Diagnostics Division, FUJIFILM Wako Pure Chemical Corporation, Amagasaki, Hyogo, Japan

10. In Vitro Diagnostics Division, FUJIFILM Corporation, Tokyo, Japan

11. Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

12. Department of Emergency and General Internal Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Abstract

Mass vaccination campaigns using mRNA vaccines against SARS-CoV-2 have begun in many countries. Serological assays to detect antibody production may be a useful tool to monitor the efficacy of SARS-CoV-2 vaccination in individuals.

Funder

Japan Agency for Medical Research and Development

FUJIFILM Wako Pure Chemical Corporation

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.01181-21

Reference34 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial